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Wild-type and mutant serotonin I A receptors were transiently expressed inCOS-7 cells using the infeetion-transfeetion variant of the vageinia virus/ 
T7 polymerase vector system. The amino acid substitutions in the transmembrane r~gions, Asp~-~Asn ~-~, Asp ~s ~Asn s~6, and Ser~9~--~Ala '~ ll 
resulted in a decrease in affinity For 5.HT by 60-100-fold, withgut affecting the affinity for the antagonist, pindolol. The binding of agonist o the 
additional mutant, Thr~99-~Ala ~'jg, was too weak to be measured, 5-HT induced GTPase activities for all receptors studied. Tlaese findings indicate 
that the residues mutated play an important role in the binding of the agonist and I~s critical roles in the binding of the antagonist pindolal. 
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1. INTRODUCTION 
The serotonin 1A receptor (5-HTIAR) is a member 
of the 7-helix, G protein-activating receptor family [ 1,2]. 
Recently the 5-HTtAR was expressed in a variety of 
mammalian cell types [3] using the vaccinia virus (VV)/ 
T7 polymerase vector system; in cardiac atrial cells, the 
expressed receptor activated K ~ channels within 1 s [4]. 
Endogenous 5-HT~AR also activates K + channels in hip- 
pocampal neurons without the involvement of known 
soluble second messengers [5], a property of the 5- 
HT~AR which may be relevant for its moderately rapid 
neurotransmitter signaling (i.e. 100 ms-1 s). Both find- 
ings are consistent with the report that in isolated 
patches, these channels can be gated directly by GTP- 
activated G~ and/or GCto subunits [6]. 
The present study extends the W/T7 polymerase vec- 
tor system to experiments on site-directed mutations for 
the 7-helix receptor family. We examine the effects of 
several amino acid residues on agonist and antagonist 
binding, and on activation of O proteins, fl-Adrenergic 
receptor (fl-AR) agonists, such as norepinephrine, share 
with 5-HT the feature of a hydroxyl group and of a 
basic amino group on opposite sides of an aromatic 
moiety, although adrenergic and 5-HT agonists have 
quite distinct structural and pharmacological proper- 
ties, 5-HT~AR agonists belong to diverse chemical 
classes but have in common a basic amino group and 
an aromatic ring which usually carries a hydroxyl, 
methoxy, or carbamoyl group which has the potential 
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for hydrogen bond formation [7,8]. Therefore, our 
choices of mutants for this initial study were guided by 
previous studies of the human and hamster /~-AR, 
which implicate aspartate and serine residues within 
several of transmembrane r gions (TMR) in ligand 
binding [9-12]. Several recent modeling studies of this 
class of receptors also suggest important roles for these 
amino acid residues [13,14]. Based on these considera- 
tions, four mutations of aspartate, serine, or threonine 
residues were made: D82N (2nd TMR), DI I6N (3rd 
TMR), S198A (5th TMR), and T199A (5th TMR). 
2. MATERIALS AND METHODS 
2.1. Cell culture 
COS-7 cells were grown in a humidified environment of 5% CO2 at 
37°C in Dulbeeeo's modified Eagle's medium supplemented with 5% 
fetal bovine serum, 2 mM L-glutamine, penicillin G (100 U/ml) and 
streptomycin (100/zg/ml), 
2.2. Expressiot~ of the 5-HTtAR 
Constructioa of the plasmid pTMI-SHTIAR [4], containing tile 
5-FIT~AR eDNA was described previously [4,15]. The receptor was 
cxpresr~l in ¢OS-7 ¢¢11s by the infection-translation protocol [3]: 
6 x 10 ~ cells were first infected with the helper virus, vTF7-3 (multiplic- 
ity of infection of 5) which expresses the bacteriophage "1"7 RNA 
polymera~, and transferal ruing Lipofeetia (Ilethesda R~earch 
Laboratories) with 10 pg of recombinant plasmids containing the 
wild-type or mutant 5-HTtAR eDNA driven by a T7 promoter in the 
specialized V'V vector pTMI. 
2.3. Preparation of membranes: receptor binding and GTPase assays 
Membranes were prepan.~l and protein levels m~sur~l as pr,vi- 
ously described [3,161. Saturation and competitive binding studies 
were performed with [~H]serotonin (23.2-29.8 Ci/mmol) and analyz,~l 
with the LIGAND program as described [I7,18]. OTPase activity was 
determined by the modified method of easel and Selinger [19] as 
described [31. 
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2.4. Mutagenesis 
pTMI-SHTIAR carries the £1(+) origin of replication. Single- 
stranded DNA of pTMI-SHT1AR was generated with the helper 
phage R408 (Promega) in~. eoli CJ236. Oligonucleotide-directed mut-
agenesis was performed using the Bio-Rad Mute-gone MI3 in vitro 
mutagenesis k t. The mutants were analyzed with restriction enzymes 
and the re~ion around the mutation was sequenced. 
2.5. Materials 
All cell culture m~lia were purchazed l'rom lrvine Scientific. Dru~s 
were obtained from the following sources: erotonin HCI, [~H]sero- 
tonin (Du-Pont New England Nuclear) and [7-~"PIGTP (Amersham 
Corp. or Du Pont-New England Nuclear). All other che'nicals were 
ultrapure or reagent grade from commercial sources. 
3. RESULTS AND DISCUSSION 
3.1. Binding of  norton! and mutated 3-HTt,tl~ 
The 5-HT~AR was pre~iously expressed in several 
mammalian cell types using both the co-infection and 
infection-transfection variants of the VV vector/T7 
RNA polymerase system ~3], with coAnfeetion giving 
about three-fold higher levels of expression than infec- 
tion-transfeetion in COS-7 cells. For both methods, the 
affinities of the expressed 5-HT~aR for a number of 
competitive inhibitors were all consistent with values 
observed for the endogenous 5-HT~AR, and confirmed 
a 5-HT1A-type pharmacology. For studies of mutant 
receptors, the infeetion-transfection protocol is the 
more appropriate technique, because mutations need 
only be made in the plasmid pTMI -SHTIAR and need 
not be transferred by homologous recombination i to 
VV. 
Receptor binding assays howed that the D82N (2rid 
TMR), D116N (3rd TMR), and S198A (Sth TMR) mu- 
tations produced a 60-100-fold ecrease in affinity for 
5-HT (Table I). However, affinities of the wild-type and 
the mutant receptors for pindolol were all approxi- 
mately the same, varying by less than 2-fold (Table I, 
Fig. 1). Mutant T199A (also in the 5th TMR) showed 
insufficient specific [~H]5-HT binding to yield a reliable 
estimate of 5-HT affinity, even though immunoblot as- 
says using a 5-HT~AR-Speeifie antibody showed expres- 
sion of all mutant receptors in the membrane fraction 
[3] (data not shown). 
3.2. GTPase activity of membrane fractions 
Because there was some variability in both the basal 
and maximal activity measurements in different infec- 
tion-transfcction experiments. GTPase activity was 
expressed as a per~ntage of the basal activity in the 
absence ofagonist. Tke data in Fig. 2 show a concentra- 
tion-dependent i crease in activity. The ECa0 value esti- 
mated for the wild-r.ype receptor for 5-HT is 4.8 riM, 
which is close to the/¢'d value of 1.8 nM found in the 
binding assay. The mutant receptors ,,,,-" required a 3",9-- 
100-fold higher concentration of 5-HT to induce com. 
parable OTPase activity. Because of the limited experi- 
mental accuracy we have not attempted to estimate the 
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Fig. 1. Bindinl~ of ~erotonin (A,B) and pindolol (C) to the wild-tyf~ 
(WT) and mutant 5-HT~ARs. Saturation bJndln/~ o£[~tf]serotonin (A, 
Scatchard plot) and competitive binding assays of serotonin (B) or 
pJndolol (C) were performed as described in Table I. Each curve 
represents the results from one experiment, The experiments were 
repeated atleast hree tim~s whh similar esults. 
EC~0 values of these mutants. It is noteworthy, however, 
that the TI99A mutation for which we were unable to 
detect binding by direct measurement did stimulate 
GTPase activity at concentrations that were only 
slightly higher than those observed for the other mu- 
tants. Thus, we conclude that the T199A receptor does 
bind agonist, but somewhat more weakly than the other 
mutants. The results clearly support he conclusion that 
all 4 mutant receptors are functional. 
3.3. Structural interpretations 
The data in the present study are in general agree- 
ment with the observations in previous studies on cat- 
echolamine receptors that the conserved aspartates in 
the 2nd and 3rd T,r,AR play an important role in agonist 
binding [9-12,20], presumably by interaction with the 
protonated amino group of the agonist. These previous 
studies do alot permit a simple interpretation as to the 
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relative roles of the aspartate r sidues in the 2nd and 3rd 
TMR; for the 5-HT~AR studied here, the two residues 
seem to play approximately equal roles in binding. It 
was also suggested previously that the recta- and para- 
hydroxyl groups of the catecholamine agonists interact 
with $204 and $207, respectively, in the 5th TMR of the 
fl-AR [11]. Mutations of the several serines in the 5th 
TMR of the D2 receptor also decreased the binding 
affinity of dopamine, but S193A had the largest and 
S194A the smallest effect (corresponding to S198A and 
T199A of the 5-HT~AR) [20]. We also find a significant 
reduction of agonist binding by the S198A mutation 
and by the T199A mutation. Simulation of interaction 
of dopamine with the D~ receptor suggests that the ag- 
onist fluctuates rapidly between different anti and 
gauche conformations [13], so it is possible that the 
amino and hydroxyl functional groups interact with 
more than one residue. 
Our results which indicate no effects of the four muta- 
tions on antagonist binding support he interpretation 
of Strader et al. [11] 'that the binding sites for agonists 
and antagonists are overlapping but not identical'. It 
has also been reported that the mutation, N385V in the 
7th TMR of the 5-HT~AR, decreases pindolol affinity by 
ca. 100-fold without affecting affinities of the agonists, 
5-HT and 8-OH-DPAT [21]. These facts lead us to pro- 
pose that the agonist binds in a pocket formed by the 
7 transmembrane h lices, with the protonated amino 
group of 5-HT interacting with the carboxylate groups 
of the aspartate residues in the 2rid and 3rd TMRs, and 
with the hydroxyl group on the indole ring of 5-HT 
interacting by hydrogen bonding with the hydroxyl 
groups of Ser toa and Thr ~99 in the 5th TMR. The data 
suggest different interactions with the structurally dif- 
ferent antagonist, pindolol. It may be that an antagonist 
can enter the binding pocket in any one of severn! non- 
Table I
Affinity and expression level of wild-type and mutant 5-H'I'IAI'~ 
O .... Kd (nM) K, (nM) 
(pmol/mg protein) serotonin 
Serotonin Pindolol 
WT 0.82 _+ 0.04 I.B :l: 0.3 1,1 ± 0.4 18 :t: 2 
D82N 4.2"1-2.1 l l0± 35 240:t:32 21 -I-6 
D116N 2.4 + 1.8 158 +_. 31 198 __. 42 30 ± 5 
S198A 6.9 ± 1.9 172 -'2 44 250 ± 61 32 ____. 6 
Membranes were prepared from COS-7 ¢¢11s 24 h after infection with 
vTF7-3 and transfeetion with the wild.type (WT) or mutant plasmid. 
B~,~ and Ka values were obtained from saturation binding using 
[aH]serotonin. Competitive binding assays were ~rformed with 1 nM 
[3H]serotonin for the wild-type receptor and 50 nM [~H]serotonin for 
the mutants./~j values for serotonln and pindolol have been corrected 
for the serotonin Kd values obtained from the saturation binding 
assays. Non-specific binding was determined in the presence of 10/~M 
serotonin for the wild-type and 50,aM serotonin for the mutants. Data 
are expressed as mean-+ S.E,M. from at least three independent 
experiments. 
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Fig. 2. Stimulation ofGTPase activity by serotonin for wild-type (WT) 
and mutant 5-HTIARs. Membranes were prepered from CO$-7 cells 
24 h after infection with vTFT-3 and transfeetion with the wild-type 
or mutant plasmid. Average basal low Km GTPase activities were 
13.9 __.3.8 (WT), 23.0- 4.5 (D$2N), 29.13- 13.3 (DIi6N), 
14.5 ± 5.16 (S198A), 14.7 :t: 1.5 (S199A) pmol/mg protein/mix. The 
same wild-type results are shown in both figures. Data of low K,~ 
GTPase activity levels were expressed as a l~rcentage of their respec- 
tive basal value from each assay. Data shown are mean +_ $.E.M. from 
at least three separate infection-translation cxperiment-~. 
productive conformations and does not need to be posi- 
tioned by simultaneous interactions with residues in the 
2rid, 3rd, and 5th TMRs to compete with agonist. In 
any case, we find it attractive to suggest that the specific 
interactions of 5-HT with Asp a-', Asp u6, Set tgs, and 
Thr t~9 contribute to a conformational change in the 
receptor leading to signal transduction. 
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